Brown KK - Search Results

1

Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis.

Kinder BW, Brown KK, Schwarz MI, Ix JH, Kervitsky A, King TE Jr. Kinder BW, et al. Among authors: brown kk. Chest. 2008 Jan;133(1):226-32. doi: 10.1378/chest.07-1948. Epub 2007 Dec 10. Chest. 2008. PMID: 18071016

2

Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis.

Collard HR, Ryu JH, Douglas WW, Schwarz MI, Curran-Everett D, King TE Jr, Brown KK. Collard HR, et al. Among authors: brown kk. Chest. 2004 Jun;125(6):2169-74. doi: 10.1378/chest.125.6.2169. Chest. 2004. PMID: 15189938

3

Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis.

Kinder BW, Brown KK, McCormack FX, Ix JH, Kervitsky A, Schwarz MI, King TE Jr. Kinder BW, et al. Among authors: brown kk. Chest. 2009 Jun;135(6):1557-1563. doi: 10.1378/chest.08-2209. Epub 2009 Mar 2. Chest. 2009. PMID: 19255294 Free PMC article.

4

Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases.

Young LR, Vandyke R, Gulleman PM, Inoue Y, Brown KK, Schmidt LS, Linehan WM, Hajjar F, Kinder BW, Trapnell BC, Bissler JJ, Franz DN, McCormack FX. Young LR, et al. Among authors: brown kk. Chest. 2010 Sep;138(3):674-81. doi: 10.1378/chest.10-0573. Epub 2010 Apr 9. Chest. 2010. PMID: 20382711 Free PMC article. Clinical Trial.

5

Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.

Collard HR, King TE Jr, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Collard HR, et al. Among authors: brown kk. Am J Respir Crit Care Med. 2003 Sep 1;168(5):538-42. doi: 10.1164/rccm.200211-1311OC. Epub 2003 May 28. Am J Respir Crit Care Med. 2003. PMID: 12773325

6

The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis.

Vourlekis JS, Schwarz MI, Cherniack RM, Curran-Everett D, Cool CD, Tuder RM, King TE Jr, Brown KK. Vourlekis JS, et al. Among authors: brown kk. Am J Med. 2004 May 15;116(10):662-8. doi: 10.1016/j.amjmed.2003.12.030. Am J Med. 2004. PMID: 15121492

7

Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis.

King TE Jr, Safrin S, Starko KM, Brown KK, Noble PW, Raghu G, Schwartz DA. King TE Jr, et al. Among authors: brown kk. Chest. 2005 Jan;127(1):171-7. doi: 10.1378/chest.127.1.171. Chest. 2005. PMID: 15653980

8

Classifying interstitial lung disease: remembrance of things past.

Brown KK, Schwarz MI. Brown KK, et al. Chest. 2006 Nov;130(5):1289-91. doi: 10.1378/chest.130.5.1289. Chest. 2006. PMID: 17098999 No abstract available.

9

Respiratory bronchiolitis-interstitial lung disease: long-term outcome.

Portnoy J, Veraldi KL, Schwarz MI, Cool CD, Curran-Everett D, Cherniack RM, King TE Jr, Brown KK. Portnoy J, et al. Among authors: brown kk. Chest. 2007 Mar;131(3):664-671. doi: 10.1378/chest.06-1885. Chest. 2007. PMID: 17356078

10

Familial pulmonary fibrosis in the United States.

Wahidi MM, Speer MC, Steele MP, Brown KK, Schwarz MI, Schwartz DA. Wahidi MM, et al. Among authors: brown kk. Chest. 2002 Mar;121(3 Suppl):30S. doi: 10.1378/chest.121.3_suppl.30s. Chest. 2002. PMID: 11893669 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

455 results

Search Page

Filters